MedTrace Logo

MRI-Guided Laser Induced Thermal Therapy

NCT01515085 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2014-05-22

No results posted yet for this study

Summary

Does MR-guided laser interstitial thermal therapy (MRgLITT) prior to chemotherapy and/or radiation give patients a beneficial increase in overall survival? Laser induced thermal therapy (LITT) is a minimally invasive procedure for destroying tissue through generation of heat.

Conditions

  • Malignant Glioma

Interventions

PROCEDURE

laser interstitial thermal therapy

residual gliomas either after debulking or biopsy evaluated for intervention with laser ablation prior to onset of adjuvant therapy

Sponsors & Collaborators

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Shabbar F Danish, MD · Rutgers, The State University of New Jersey

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01515085 on ClinicalTrials.gov